TAMs can promote carcinogenesis in cSCC by releasing cytokines, including vascular endothelial growth factor-C (VEGF-C) and matrix metalloproteinase (MMP) 9 and 11, which stimulate lymph-angiogenesis and tumor growth [18,19]. This evidence concerns the gene VEGFC and neoplasm.